Shawn Singh - Jun 30, 2023 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Jun 30, 2023
Transactions value $
$265
Form type
4
Date filed
7/5/2023, 04:05 PM
Previous filing
Jan 3, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $265 +167 +3.15% $1.59* 5.47K Jun 30, 2023 Direct F1
holding VTGN Common Stock 20.9K Jun 30, 2023 By The 1997 Singh Family Trust U/R/D 05/29/97
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan ("ESPP").